Knockouts model the 100 best-selling drugs—will they model the next 100?

[1]  A. Hopkins,et al.  The druggable genome , 2002, Nature Reviews Drug Discovery.

[2]  B. Yandell,et al.  Loss of stearoyl–CoA desaturase-1 function protects mice against adiposity , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[3]  H. Hsiung,et al.  Targeted disruption of the melanin-concentrating hormone receptor-1 results in hyperphagia and resistance to diet-induced obesity. , 2002, Endocrinology.

[4]  J. Molkentin,et al.  Defective T cell development and function in calcineurin Aβ-deficient mice , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[5]  K. Austen,et al.  Targeted Gene Disruption Reveals the Role of Cysteinyl Leukotriene 1 Receptor in the Enhanced Vascular Permeability of Mice Undergoing Acute Inflammatory Responses* , 2002, The Journal of Biological Chemistry.

[6]  William H. Majoros,et al.  A Comparison of Whole-Genome Shotgun-Derived Mouse Chromosome 16 and the Human Genome , 2002, Science.

[7]  H. Kantarjian,et al.  In vitro effects of STI 571‐containing drug combinations on the growth of Philadelphia‐positive chronic myelogenous leukemia cells , 2002, Cancer.

[8]  Yue Feng,et al.  Melanin-concentrating hormone 1 receptor-deficient mice are lean, hyperactive, and hyperphagic and have altered metabolism , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[9]  C. Rao,et al.  Consequences of targeted inactivation of LH receptors , 2002, Molecular and Cellular Endocrinology.

[10]  Masataka Mori,et al.  Targeted disruption of the Chop gene delays endoplasmic reticulum stress-mediated diabetes. , 2002, The Journal of clinical investigation.

[11]  M. Rogers,et al.  Identification of a bisphosphonate that inhibits isopentenyl diphosphate isomerase and farnesyl diphosphate synthase. , 2002, Biochemical and biophysical research communications.

[12]  M. Peters-Golden,et al.  Protection from pulmonary fibrosis in leukotriene-deficient mice. , 2002, American journal of respiratory and critical care medicine.

[13]  A. Sands,et al.  In vivo drug target discovery: identifying the best targets from the genome. , 2001, Current opinion in biotechnology.

[14]  Margaret S. Wu,et al.  Role of AMP-activated protein kinase in mechanism of metformin action. , 2001, The Journal of clinical investigation.

[15]  W. Koch,et al.  Transgenic studies of cardiac adrenergic receptor regulation. , 2001, The Journal of pharmacology and experimental therapeutics.

[16]  S. V. Prasad,et al.  β-Adrenergic axis and heart disease , 2001 .

[17]  Marek Jutel,et al.  Histamine regulates T-cell and antibody responses by differential expression of H1 and H2 receptors , 2001, Nature.

[18]  I. Lucki,et al.  Antidepressant-like behavioral effects in 5-hydroxytryptamine(1A) and 5-hydroxytryptamine(1B) receptor mutant mice. , 2001, The Journal of pharmacology and experimental therapeutics.

[19]  B. Koller,et al.  Mixed messages: modulation of inflammation and immune responses by prostaglandins and thromboxanes. , 2001, The Journal of clinical investigation.

[20]  F. Monsma,et al.  Molecular identification and characterization of the platelet ADP receptor targeted by thienopyridine antithrombotic drugs. , 2001, The Journal of clinical investigation.

[21]  Kelvin Y. Kwan,et al.  Mice lacking DNA topoisomerase IIIβ develop to maturity but show a reduced mean lifespan , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[22]  Martin M. Matzuk,et al.  Continuous Fatty Acid Oxidation and Reduced Fat Storage in Mice Lacking Acetyl-CoA Carboxylase 2 , 2001, Science.

[23]  M. Jackerott,et al.  Compensatory responses in mice carrying a null mutation for Ins1 or Ins2. , 2001, Diabetes.

[24]  C. Poulter,et al.  Structure-activity relationships for inhibition of farnesyl diphosphate synthase in vitro and inhibition of bone resorption in vivo by nitrogen-containing bisphosphonates. , 2001, The Journal of pharmacology and experimental therapeutics.

[25]  L. Ballou,et al.  The genetic ablation of cyclooxygenase 2 prevents the development of autoimmune arthritis. , 2000, Arthritis and rheumatism.

[26]  P. Chambon,et al.  Effect of single and compound knockouts of estrogen receptors alpha (ERalpha) and beta (ERbeta) on mouse reproductive phenotypes. , 2000, Development.

[27]  F. Tronche,et al.  Molecular Genetic Analysis of Glucocorticoid Signaling Using the Cre/loxP System , 2000, Biological chemistry.

[28]  Yue Feng,et al.  Inactivation of the mouse melanocortin-3 receptor results in increased fat mass and reduced lean body mass , 2000, Nature Genetics.

[29]  J. Vane,et al.  Nociception in cyclooxygenase isozyme-deficient mice. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[30]  B. Mitchell,et al.  Inhibition of T lymphocyte activation in mice heterozygous for loss of the IMPDH II gene. , 2000, The Journal of clinical investigation.

[31]  Y. Komiya,et al.  Multiple functional defects in peripheral autonomic organs in mice lacking muscarinic acetylcholine receptor gene for the M3 subtype. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[32]  T. Doetschman,et al.  Stomachs of Mice Lacking the Gastric H,K-ATPase α-Subunit Have Achlorhydria, Abnormal Parietal Cells, and Ciliated Metaplasia* , 2000, The Journal of Biological Chemistry.

[33]  Takashi Kobayashi,et al.  Abnormal functional and morphological regulation of the gastric mucosa in histamine H2 receptor-deficient mice. , 2000, The Journal of clinical investigation.

[34]  J. Gustafsson,et al.  Estrogen receptor specificity in the regulation of skeletal growth and maturation in male mice. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[35]  Fei Xu,et al.  Mice lacking the norepinephrine transporter are supersensitive to psychostimulants , 2000, Nature Neuroscience.

[36]  J. Grove,et al.  The Intracellular Target for the Antiresorptive Aminobisphosphonate Drugs in Dictyostelium discoideum Is the Enzyme Farnesyl Diphosphate Synthase , 2000, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[37]  R. Sartor,et al.  Impaired mucosal defense to acute colonic injury in mice lacking cyclooxygenase-1 or cyclooxygenase-2. , 2000, The Journal of clinical investigation.

[38]  P. Carmeliet,et al.  Blood Coagulation Factor X Deficiency Causes Partial Embryonic Lethality and Fatal Neonatal Bleeding in Mice , 2000, Thrombosis and Haemostasis.

[39]  R. Evans,et al.  Improved insulin-sensitivity in mice heterozygous for PPAR-γ deficiency , 2000 .

[40]  R. DuBois,et al.  The role of cyclooxygenases in inflammation, cancer, and development , 1999, Oncogene.

[41]  S. Reddy,et al.  Genetic evidence for distinct roles of COX-1 and COX-2 in the immediate and delayed phases of prostaglandin synthesis in mast cells. , 1999, Biochemical and biophysical research communications.

[42]  C. Funk,et al.  Insight into prostaglandin, leukotriene, and other eicosanoid functions using mice with targeted gene disruptions. , 1999, Prostaglandins & other lipid mediators.

[43]  M. Low,et al.  Dopamine D4 Receptor-Knock-Out Mice Exhibit Reduced Exploration of Novel Stimuli , 1999, The Journal of Neuroscience.

[44]  R. Langenbach,et al.  Cyclooxygenase‐deficient Mice: A Summary of Their Characteristics and Susceptibilities to Inflammation and Carcinogenesis , 1999, Annals of the New York Academy of Sciences.

[45]  R. Langenbach,et al.  Cyclooxygenase knockout mice: models for elucidating isoform-specific functions. , 1999, Biochemical pharmacology.

[46]  P. Gleeson,et al.  Gastric H(+),K(+)-adenosine triphosphatase beta subunit is required for normal function, development, and membrane structure of mouse parietal cells. , 1999, Gastroenterology.

[47]  R Hen,et al.  5-HT1B Receptor Knock-Out Mice Exhibit Increased Exploratory Activity and Enhanced Spatial Memory Performance in the Morris Water Maze , 1999, The Journal of Neuroscience.

[48]  K. Desai,et al.  Targeted Disruption of the β2 Adrenergic Receptor Gene* , 1999, The Journal of Biological Chemistry.

[49]  D. Bernstein,et al.  Cardiovascular and Metabolic Alterations in Mice Lacking Both β1- and β2-Adrenergic Receptors* , 1999, The Journal of Biological Chemistry.

[50]  K. Korach,et al.  Targeted Disruption of the Estrogen Receptor-α Gene in Female Mice: Characterization of Ovarian Responses and Phenotype in the Adult. , 1999, Endocrinology.

[51]  Y. Wang,et al.  The febrile response to lipopolysaccharide is blocked in cyclooxygenase-2−/−, but not in cyclooxygenase-1−/− mice , 1999, Brain Research.

[52]  E. Harrison,et al.  Intestinal absorption of dietary cholesteryl ester is decreased but retinyl ester absorption is normal in carboxyl ester lipase knockout mice. , 1999, Biochemistry.

[53]  M. Geyer,et al.  Increased Exploratory Activity and Altered Response to LSD in Mice Lacking the 5-HT5A Receptor , 1999, Neuron.

[54]  Takeshi Watanabe,et al.  Augmentation of Antigen Receptor–mediated Responses by Histamine H1 Receptor Signaling , 1999, Journal of Experimental Medicine.

[55]  J. Gustafsson,et al.  Generation and reproductive phenotypes of mice lacking estrogen receptor beta. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[56]  J. Kauer,et al.  Perturbed dentate gyrus function in serotonin 5-HT2C receptor mutant mice. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[57]  L H Parsons,et al.  Elevated anxiety and antidepressant-like responses in serotonin 5-HT1A receptor mutant mice. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[58]  R Hen,et al.  Serotonin receptor 1A knockout: an animal model of anxiety-related disorder. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[59]  M. Kaplan,et al.  Decreased Neonatal Dietary Fat Absorption and T Cell Cytotoxicity in Pancreatic Lipase-related Protein 2-Deficient Mice* , 1998, The Journal of Biological Chemistry.

[60]  Sheila J. Jones,et al.  Impaired osteoclastic bone resorption leads to osteopetrosis in cathepsin-K-deficient mice. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[61]  M Toth,et al.  Increased anxiety of mice lacking the serotonin1A receptor. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[62]  D. Rohrer.  Physiological consequences of β-adrenergic receptor disruption , 1998, Journal of Molecular Medicine.

[63]  J. Giacobino,et al.  Metabolic response to various β‐adrenoceptor agonists in β3‐adrenoceptor knockout mice: Evidence for a new β‐adrenergic receptor in brown adipose tissue , 1998 .

[64]  T. Watanabe,et al.  Behavioural characterization and amounts of brain monoamines and their metabolites in mice lacking histamine H1 receptors , 1998, Neuroscience.

[65]  M. Neuberger,et al.  Mice carrying a CD20 gene disruption , 1998, Immunogenetics.

[66]  D. R. Smith,et al.  Behavioural assessment of mice lacking D1A dopamine receptors , 1998, Neuroscience.

[67]  J. Drews.  Biotechnology's metamorphosis into a drug discovery industry , 1998, Nature Biotechnology.

[68]  M. Low,et al.  Locomotor Activity in D2 Dopamine Receptor-Deficient Mice Is Determined by Gene Dosage, Genetic Background, and Developmental Adaptations , 1998, The Journal of Neuroscience.

[69]  K. Desai,et al.  Alterations in dynamic heart rate control in the β1-adrenergic receptor knockout mouse. , 1998, American Journal of Physiology. Heart and Circulatory Physiology.

[70]  B. Lowell.  Using gene knockout and transgenic techniques to study the physiology and pharmacology of beta3-adrenergic receptors. , 1998, Endocrine journal.

[71]  J. Giacobino,et al.  (-)-CGP 12177 causes cardiostimulation and binds to cardiac putative beta 4-adrenoceptors in both wild-type and beta 3-adrenoceptor knockout mice. , 1998, Molecular pharmacology.

[72]  T. Watanabe,et al.  Targeting disruption of histamine H1 receptors in mice: behavioral and neurochemical characterization. , 1998, Life sciences.

[73]  S. Tonegawa,et al.  Dopamine D3 Receptor Mutant Mice Exhibit Increased Behavioral Sensitivity to Concurrent Stimulation of D1 and D2 Receptors , 1997, Neuron.

[74]  J. A. Chester,et al.  Mice Lacking Dopamine D4 Receptors Are Supersensitive to Ethanol, Cocaine, and Methamphetamine , 1997, Cell.

[75]  L. Old,et al.  Characterization of tumor necrosis factor-deficient mice. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[76]  J. Sheller,et al.  5-Lipoxygenase products are necessary for ovalbumin-induced airway responsiveness in mice. , 1997, The American journal of physiology.

[77]  Murray H. Brilliant,et al.  Mice devoid of γ-aminobutyrate type A receptor β3 subunit have epilepsy, cleft palate, and hypersensitive behavior , 1997 .

[78]  I. Sora,et al.  Opiate receptor knockout mice define mu receptor roles in endogenous nociceptive responses and morphine-induced analgesia. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[79]  R. Cone,et al.  Targeted Disruption of the Melanocortin-4 Receptor Results in Obesity in Mice , 1997, Cell.

[80]  K. Kaitin,et al.  THE NEW DRUG APPROVALS OF 1993, 1994, AND 1995: TRENDS IN DRUG DEVELOPMENT , 1997, American journal of therapeutics.

[81]  Bruno C. Hancock,et al.  Suppression of Intestinal Polyposis in Apc Δ716 Knockout Mice by Inhibition of Cyclooxygenase 2 (COX-2) , 1996, Cell.

[82]  I. Taniuchi,et al.  Impaired locomotor activity and exploratory behavior in mice lacking histamine H1 receptors. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[83]  G. Kollias,et al.  Immune and inflammatory responses in TNF alpha-deficient mice: a critical requirement for TNF alpha in the formation of primary B cell follicles, follicular dendritic cell networks and germinal centers, and in the maturation of the humoral immune response , 1996, The Journal of experimental medicine.

[84]  G. Barsh,et al.  Targeted disruption of the mouse beta1-adrenergic receptor gene: developmental and cardiovascular effects. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[85]  M. Capecchi,et al.  Mice lacking angiotensin-converting enzyme have low blood pressure, renal pathology, and reduced male fertility. , 1996, Laboratory investigation; a journal of technical methods and pathology.

[86]  B. Lamothe,et al.  Targeted disruption of the insulin receptor gene in the mouse results in neonatal lethality. , 1996, The EMBO journal.

[87]  R. Mark Wightman,et al.  Hyperlocomotion and indifference to cocaine and amphetamine in mice lacking the dopamine transporter , 1996, Nature.

[88]  M. Buhot,et al.  5-HT1B receptor knock out — behavioral consequences , 1995, Behavioural Brain Research.

[89]  R. Langenbach,et al.  Prostaglandin synthase 2 gene disruption causes severe renal pathology in the mouse , 1995, Cell.

[90]  Hyung-Suk Kim,et al.  Prostaglandin synthase 1 gene disruption in mice reduces arachidonic acid-induced inflammation and indomethacin-induced gastric ulceration , 1995, Cell.

[91]  Rudolf Jaenisch,et al.  Generation of committed erythroid BFU-E and CFU-E progenitors does not require erythropoietin or the erythropoietin receptor , 1995, Cell.

[92]  J. Rossant,et al.  Mice lacking all isoforms of retinoic acid receptor β develop normally and are susceptible to the teratogenic effects of retinoic acid , 1995, Mechanisms of Development.

[93]  Masaki Sugiura,et al.  Angiotensin II Type 1a Receptor-deficient Mice with Hypotension and Hyperreninemia (*) , 1995, The Journal of Biological Chemistry.

[94]  W. Schmid,et al.  Molecular genetic analysis of glucocorticoid signalling in development , 1995, The Journal of Steroid Biochemistry and Molecular Biology.

[95]  J. Charles Jennette,et al.  Male–female differences in fertility and blood pressure in ACE-deficient mice , 1995, Nature.

[96]  P. Mannon,et al.  Regulation of blood pressure by the type 1A angiotensin II receptor gene. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[97]  Ming Xu,et al.  Dopamine D1 receptor mutant mice are deficient in striatal expression of dynorphin and in dopamine-mediated behavioral responses , 1994, Cell.

[98]  C. Funk,et al.  Role of leukotrienes revealed by targeted disruption of the 5-lipoxygenase gene , 1994, Nature.

[99]  A R Dunn,et al.  Mice lacking granulocyte colony-stimulating factor have chronic neutropenia, granulocyte and macrophage progenitor cell deficiency, and impaired neutrophil mobilization. , 1994, Blood.

[100]  P. Chambon,et al.  Function of retinoic acid receptor γ in the mouse , 1993, Cell.

[101]  R. Jaenisch,et al.  Normal development and growth of mice carrying a targeted disruption of the alpha 1 retinoic acid receptor gene. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[102]  A. Sands,et al.  Full-speed mammalian genetics: in vivo target validation in the drug discovery process. , 2002, Trends in biotechnology.

[103]  L. Meinel,et al.  Differential Distribution of-Adrenergic Receptor Subtypes in Blood Vessels of Knockout Mice Lacking 1-or 2-Adrenergic Receptors , 2001 .

[104]  M. Lohse,et al.  Abolition of (-)-CGP 12177-evoked cardiostimulation in double β1/β2-adrenoceptor knockout mice. Obligatory role of β1-adrenoceptors for putative β4-adrenoceptor pharmacology , 2000, Naunyn-Schmiedeberg's Archives of Pharmacology.

[105]  G. Rodan,et al.  Alendronate is a specific, nanomolar inhibitor of farnesyl diphosphate synthase. , 2000, Archives of biochemistry and biophysics.

[106]  O. Morteau,et al.  Prostaglandins and inflammation: the cyclooxygenase controversy. , 2000, Archivum immunologiae et therapiae experimentalis.

[107]  P. Chambon,et al.  Effect of single and compound knockouts of estrogen receptors α (ERα) and β (ERβ) on mouse reproductive phenotypes , 2000 .

[108]  Danhong Lu,et al.  A mutation in the insulin 2 gene induces diabetes with severe pancreatic beta-cell dysfunction in the Mody mouse. , 1999, The Journal of clinical investigation.

[109]  K. Desai,et al.  The developmental and physiological consequences of disrupting genes encoding beta 1 and beta 2 adrenoceptors. , 1998, Advances in pharmacology.

[110]  Mark D. Johnson,et al.  Early neonatal death in mice homozygous for a null allele of the insulin receptor gene , 1996, Nature Genetics.